drugset / Trial / NCT00496236

Radiotherapy, Cetuximab, and Injections of TNFerade™ Biologic for Elderly or Frail Patients With Head and Neck Cancer

NCT00496236 ↗

Phase 1/2 Completed GenVec
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study is looking at the safety and tolerability of TNFeradeä Biologic combined with conventional once daily radiation therapy in elderly or frail patients with new onset locally advanced head and neck tumors.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject TNFerade biologic Unknown — Other

Indications